Comparison of the Short-term Outcomes of Using DST and PPH Staplers in the Treatment of Grade III and IV Hemorrhoids
Taipei Medical University Shuang-Ho Hospital
1 other identifier
observational
2
1 country
1
Brief Summary
The hemorrhoidal disease affects approximately 4.4%-36% of the general population, and it has been estimated that \>50% of the population aged \>50 years experiences hemorrhoidal problems . Traditional hemorrhoidectomy, including Milligan-Morgan, Ferguson, and Whitehead procedures , are known to cause significant postoperative pain and discomfort and result in a poor quality of life after operation. Since the first introduction of the novel procedure hemorrhoidopexy by Longo in 1998, it has been considered as a safe procedure causing less postoperative pain and resulting in earlier recovery; furthermore, the patients are able to resume their normal daily life and work. The PPH stapler (Ethicon Endo-Surgery, Inc. Cincinnati, OH, USA) was also first introduced in 1998 as a device to perform this procedure. Subsequently, a new device, the DST stapler (Covidien, Mansfield, MA, USA), was introduced in 2008 with some structural differences, including a detachable anvil, three anchor points over different levels, a larger case, and different agraffe sizes. However, the majority of current studies have been focusing on the use of PPH stapler for hemorrhoidopexy, and comparison with the DST stapler has been rarely discussed. One randomized controlled trial that compared between the PPH stapler and the DST stapler reported that the DST stapler demonstrated a better hemostatic ability and allowed the resection of a larger area of mucosal prolapse; however, that trial focused only on bleeding among the postoperative complications. Currently, only a limited number of studies have compared these two devices in terms of pain, complications, and anorectal stricture incidence rate. The present investigation is a matched cohort-control study aimed to compare the postoperative short-term outcomes among patients with grade III and IV hemorrhoids who were treated with either the PPH or the DST stapler. The specimen surface area and the relationships with complications were also analyzed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 5, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 5, 2019
CompletedFirst Submitted
Initial submission to the registry
August 14, 2019
CompletedFirst Posted
Study publicly available on registry
August 15, 2019
CompletedAugust 19, 2019
August 1, 2019
6 months
August 14, 2019
August 15, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Complication
Post-OP bleeding, urinary retention, anaorectal stricture, PPH syndrome
3 months
Study Arms (1)
PPH/DST
Patients underwent hemorrhoidopexy by PPH or DST stapler.
Interventions
Eligibility Criteria
Patients with grade III and IV hemorrhoid underwent stapled hemorrhoidopexy
You may qualify if:
- Grade III and grade IV hemorrhoid
You may not qualify if:
- Anal fistula, rectal polyo\\p
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Taipei Medical University Shuang-Ho Hospital
New Taipei City, 235, Taiwan
Biospecimen
After the surgery, the ring of the excised anorectal mucosa was cut open and flattened on a surgical towel as shown in Figure 2. The presence of muscle in the specimen was confirmed grossly and photographed. The entire surface area of the mucosa, muscle and the muscle/mucosa ratio were measured using the ImageJ software (National Institutes of Health, Bethesda, MD, USA).
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Tung-Cheng Chang, MD, PHD
Taipei Medical University Shuang Ho Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief of colorectal surgery
Study Record Dates
First Submitted
August 14, 2019
First Posted
August 15, 2019
Study Start
September 5, 2018
Primary Completion
February 28, 2019
Study Completion
April 5, 2019
Last Updated
August 19, 2019
Record last verified: 2019-08